EFALIZUMAB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 157 adverse event reports in the FDA FAERS database where EFALIZUMAB was used for Psoriasis.
Most Reported Side Effects for EFALIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 56 | 24.4% | 56 | 2 |
| Psoriasis | 55 | 23.9% | 3 | 13 |
| Pruritus | 35 | 15.2% | 8 | 1 |
| Erythema | 28 | 12.2% | 4 | 0 |
| Drug ineffective | 26 | 11.3% | 3 | 6 |
| Pain | 25 | 10.9% | 10 | 1 |
| Decreased appetite | 24 | 10.4% | 0 | 0 |
| Hypersensitivity | 24 | 10.4% | 1 | 1 |
| Vomiting | 24 | 10.4% | 0 | 2 |
| Nausea | 23 | 10.0% | 1 | 0 |
| Condition aggravated | 22 | 9.6% | 0 | 8 |
| Myalgia | 22 | 9.6% | 0 | 0 |
| Fatigue | 20 | 8.7% | 0 | 0 |
| Skin exfoliation | 19 | 8.3% | 5 | 0 |
| Skin plaque | 12 | 5.2% | 6 | 0 |
Other Indications for EFALIZUMAB
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)